According to Wei Hsu, professor at the University of Rochester Medical Centre in US, the goal is to better understand and find stem-cell therapy for a condition known as craniosynostosis, a skull deformity in infants.
Craniosynostosis often leads to developmental delays and life-threatening elevated pressure in the brain.
The findings contribute to an emerging field involving tissue engineering that uses stem cells and other materials to invent superior ways to replace damaged craniofacial bones in humans due to congenital disease, trauma, or cancer surgery, researchers said.
Because of a unique expression pattern of the Axin2 gene in the skull, the lab then began investigating the activity of Axin2-expressing cells and their role in bone formation, repair and regeneration.
Also Read
Their latest evidence shows that stem cells central to skull formation are contained within Axin2 cell populations, comprising about 1 per cent - and that the lab tests used to uncover the skeletal stem cells might also be useful to find bone diseases caused by stem cell abnormalities.
The study was published in the journal Nature Communications.